Trials / Not Yet Recruiting
Not Yet RecruitingNCT07188285
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
Mass Spectrometry-based Immune Profiling in Peripheral Blood of Autoimmune Diseases
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Based on mass spectrometry flow method, this study analyzed the typing of new T, B, NK and DC cell subsets in peripheral blood of common autoimmune diseases and their correlation with disease activity, aiming at establishing an early screening and diagnosis model of autoimmune diseases.
Detailed description
The study will include patients with systemic lupus erythematosus, Sjogren's syndrome, inflammatory myopathy, systemic sclerosis, vasculitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis and gouty arthritis and healthy controls. About 50 patients of each type are required. The patients are in a state of disease activity and do not use biological agents. Their peripheral blood will be detected by mass spectrometry.
Conditions
- Systemic Lupus Erthematosus
- Sjogren's Syndrome
- Inflammatory Myopathies
- Systemic Sclerosis (SSc)
- Vasculitis
- Rheumatoid Arthritis (RA)
- Ankylosing Spondylitis
- Osteoarthritis
- Gouty Arthritis (GA)
- Psoriatic Arthritis (PsA)
- Healthy Controls
Timeline
- Start date
- 2025-09-16
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
- First posted
- 2025-09-23
- Last updated
- 2025-09-23
Source: ClinicalTrials.gov record NCT07188285. Inclusion in this directory is not an endorsement.